Agios Pharmaceuticals (AGIO) shares were up 27% in recent pre-market trade after saying this weekend that data from a study on the AG-221 drug in patients with advanced blood cancers showed “promising” clinical activity. AGIO is in the upper half of the 52-week range between $15.77 and $49.79. The purpose of the phase 1 program…
L & L Energy Requests to be Delisted from NASDAQ
L & L Energy (LLEN) which has energy (coal) operations in China, has notified its intention to voluntarily delist from the NASDAQ. The company’s management has voted to submit a notification to NASDAQ about their decision to voluntarily delist its common stock from the NASDAQ.
GenCorp’s Aerojet Rocketdyne has been awarded a new contract
Aerojet Rocketdyne has been awarded a new contract. There will be two phases of the contract. Recently, GY’s shares were trading at $17.33.